These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20610991)

  • 21. Combining functional imaging with brain stimulation in Parkinson's disease.
    Obeso I; Ray NJ; Antonelli F; Cho SS; Strafella AP
    Int Rev Psychiatry; 2011 Oct; 23(5):467-75. PubMed ID: 22200136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocomputational models of motor and cognitive deficits in Parkinson's disease.
    Wiecki TV; Frank MJ
    Prog Brain Res; 2010; 183():275-97. PubMed ID: 20696325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study.
    Elsinger CL; Rao SM; Zimbelman JL; Reynolds NC; Blindauer KA; Hoffmann RG
    J Int Neuropsychol Soc; 2003 Nov; 9(7):1088-98. PubMed ID: 14738289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic pedunculopontine nucleus stimulation restores functional connectivity.
    Schweder PM; Joint C; Hansen PC; Green AL; Quaghebeur G; Aziz TZ
    Neuroreport; 2010 Dec; 21(17):1065-8. PubMed ID: 20926975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms compensating for dopamine loss in early Parkinson disease.
    Brotchie J; Fitzer-Attas C
    Neurology; 2009 Feb; 72(7 Suppl):S32-8. PubMed ID: 19221312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective and neurorestorative strategies for Parkinson's disease.
    Dawson TM; Dawson VL
    Nat Neurosci; 2002 Nov; 5 Suppl():1058-61. PubMed ID: 12403986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait.
    Tessitore A; Amboni M; Esposito F; Russo A; Picillo M; Marcuccio L; Pellecchia MT; Vitale C; Cirillo M; Tedeschi G; Barone P
    Parkinsonism Relat Disord; 2012 Jul; 18(6):781-7. PubMed ID: 22510204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compensatory changes at the cerebral cortical level after spinal cord injury.
    Nishimura Y; Isa T
    Neuroscientist; 2009 Oct; 15(5):436-44. PubMed ID: 19826168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.
    van den Berge SA; van Strien ME; Korecka JA; Dijkstra AA; Sluijs JA; Kooijman L; Eggers R; De Filippis L; Vescovi AL; Verhaagen J; van de Berg WD; Hol EM
    Brain; 2011 Nov; 134(Pt 11):3249-63. PubMed ID: 22075520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits.
    Calabresi P; Galletti F; Saggese E; Ghiglieri V; Picconi B
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S259-62. PubMed ID: 18267247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered directional connectivity in Parkinson's disease during performance of a visually guided task.
    Tropini G; Chiang J; Wang ZJ; Ty E; McKeown MJ
    Neuroimage; 2011 Jun; 56(4):2144-56. PubMed ID: 21402160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.
    Tassorelli C; Armentero MT; Greco R; Fancellu R; Sandrini G; Nappi G; Blandini F
    Brain Res; 2007 Oct; 1176():53-61. PubMed ID: 17884026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson's disease: an MEG study.
    Stoffers D; Bosboom JL; Wolters ECh; Stam CJ; Berendse HW
    Exp Neurol; 2008 Sep; 213(1):191-5. PubMed ID: 18590728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
    Braak H; de Vos RA; Bohl J; Del Tredici K
    Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
    Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ
    Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.